spacer
home > ebr > winter 2003 > in conversation with mary harney
PUBLICATIONS
European Biopharmaceutical Review

In conversation with Mary Harney

Mary Harney is the Irish Deputy Prime Minister and Minister for Enterprise Trade and Employment. She has had a direct hand in driving Ireland's recent impressive science research foundation programmes, identified as critical if Ireland was to underpin an emerging biotechnology industry on the back of decades of inward investment in pharmaceutical manufacturing expertise. A Tainiste, to give Mrs Harney her true political title in Ireland, is equally outspoken on the importance of knowledge-based industry - and biotechnology in particular - to future European economic growth along with the need for political will to replace rhetoric at the highest level. As incoming President of the EU Competitiveness Council, which oversees the EU's life sciences biotechnology strategy, Mrs Harney represented the most relevant and senior of political commentators to bring the political message at the Opening Plenary session of the CORDIA-EuropaBio Convention in December 2003.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ireland Makes its Mark in Europe in the Opening Session of the Inaugural CORDIA-EuropaBio Convention, Vienna, December 2003

By Dr Helen Abbott, Chair Editorial Board of EBR and Member of Executive Steering Group, CORDIA-EuropaBio Convention 2003

spacer
Mary Harney
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

Achieve full compliance with tamper-verification pharma solutions

UPM Raflatac

UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement